Hamidreza Jamaati to Humans
This is a "connection" page, showing publications Hamidreza Jamaati has written about Humans.
Connection Strength
0.051
-
Coronavirus-disease-2019-induced antiphospholipid-like syndrome: a case report. J Med Case Rep. 2021 Jul 29; 15(1):408.
Score: 0.008
-
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947.
Score: 0.007
-
Dynamic of alveolar physiology. J Appl Physiol (1985). 2018 02 01; 124(2):523-524.
Score: 0.006
-
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107961.
Score: 0.002
-
Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727.
Score: 0.002
-
COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol. 2021; 11:563085.
Score: 0.002
-
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther. 2021 01 29; 12(1):91.
Score: 0.002
-
Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra. Int Immunopharmacol. 2021 Apr; 93:107407.
Score: 0.002
-
Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329.
Score: 0.002
-
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021 Nov-Dec; 27(6):486-492.
Score: 0.002
-
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205.
Score: 0.002
-
Silent hypoxia: higher NO in red blood cells of COVID-19 patients. BMC Pulm Med. 2020 Oct 16; 20(1):269.
Score: 0.002
-
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
Score: 0.002
-
Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341.
Score: 0.002
-
Good's Syndrome-Association of the Late Onset Combined Immunodeficiency with Thymoma: Review of Literature and Case Report. Iran J Allergy Asthma Immunol. 2018 Feb; 17(1):85-93.
Score: 0.002
-
Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells. J Crit Care. 2018 04; 44:161-167.
Score: 0.001
-
Identification of antigens from nosocomial Acinetobacter baumannii clinical isolates in sera from ICU staff and infected patients using the antigenome technique. World J Microbiol Biotechnol. 2017 Sep 30; 33(10):189.
Score: 0.001
-
Immunoglobulin Free Light Chains in the Pathogenesis of Lung Disorders. Iran J Allergy Asthma Immunol. 2017 Aug; 16(4):282-288.
Score: 0.001
-
Paecilomyces formosus Infection in an Adult Patient with Undiagnosed Chronic Granulomatous Disease. J Clin Immunol. 2017 05; 37(4):342-346.
Score: 0.001
-
Pattern recognitions receptors in immunodeficiency disorders. Eur J Pharmacol. 2017 Aug 05; 808:49-56.
Score: 0.001
-
Prevalence of snoring and the risk of sleep apnea in hospital staff. Work. 2016; 55(4):765-772.
Score: 0.001